Sonata Shows Advantage In Sleep Induction Over Comparable Drugs - EPAR

Wyeth-Ayerst's hypnotic agent Sonata (zaleplon) showed an advantage over comparable insomnia agents in the induction of sleep, the Committee for Proprietary Medicinal Products stated in its European Public Assessment Report for the product, released May 5.

More from Archive

More from Pink Sheet